-
Dodgers DEFEAT Yankees in Game 2, Shohei Ohtani Injury: David Ortiz, Derek Jeter, Alex Rodriguez - 7 mins ago
-
How my investigation led to sex trafficking charges against ex-boss - 18 mins ago
-
Ikorodu City coach confident ahead of Enyimba clash - 23 mins ago
-
Suspect at large after triple stabbing at New Westminster casino – BC - 41 mins ago
-
Less partying, more skiing: How to have a ‘grown-up’ ski season in your 40s - 43 mins ago
-
Google Photos Will Now Add Labels to Images Edited Using AI Tools - 44 mins ago
-
Mohammad Rizwan set to become Pakistan’s white-ball captain, PCB to announce soon - about 1 hour ago
-
The social changes fuelling the men v women election - about 1 hour ago
-
Topuria keeps promise as first man to stop Max Holloway - about 1 hour ago
-
Iwobi Disappointed With Fulham’s Draw At Everton - 2 hours ago
Pfizer's Activist Battle Might Fizzle—but Its Stock Probably Won't
The pharmaceutical company’s stock is relatively cheap, representing an opportunity for patient value investors.
Source link